Regencell Bioscience Holdings Limited (RGC)
NASDAQ
$6.22+$0.0500 (+0.81%) on the dayAs of the close; data may be delayed.
RGC price, last 12 months
Key stats
- Previous close
- $6.17
- Open
- $6.25
- Day range
- $6.06 – $6.25
- 52-week range
- $4.51 – $69.00
- Volume
- 37.6K
- Avg volume (20 days)
- 176.2K
- Market cap
- $3.1B
Performance
1W+7.4%
1M+13.1%
3M−4.0%
6M−75.5%
YTD−70.4%
1Y−57.3%
vs S&P 500, 1Y−74.1 pts
Technicals and fundamentals
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
- Listed on
- NASDAQ
- Market cap
- $3.1B